PPAR Ligands for Cancer Chemoprevention
2008
PPAR Ligands for Cancer Chemoprevention
publication
Evidence: moderate
Author Information
Author(s): Yumiko Yasui, Mihye Tanaka, Takuji Tanaka
Primary Institution: Kanazawa Medical University
Hypothesis
The study investigates the role of PPAR ligands in cancer prevention and treatment.
Conclusion
PPAR ligands may serve as promising agents for cancer chemoprevention and treatment.
Supporting Evidence
- PPARs are involved in tumor progression and differentiation.
- Activation of PPARs can lead to anti-cancer effects.
- Different PPAR ligands have varying effects on cancer types.
Takeaway
PPARs are proteins that help control how cells grow and can be used to help prevent cancer.
Methodology
The review summarizes existing data on PPAR ligands and their effects on cancer.
Limitations
The review does not provide new experimental data but summarizes existing literature.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website